Advance of Circulating Tumor Cells in the Prognosis and Management of Endometrial Cancer

被引：0
|
作者：
Li, Hongli [1 ]
Liu, Chang [1 ]
Wang, Jing [1 ]
Xu, Feixue [1 ]
Yang, Yongxiu [1 ]
Liang, Xiaolei [1 ]
机构：
[1] Lanzhou Univ, Hosp 1, Dept Obstet & Gynecol, Key Lab Gynecol Oncol Gansu Prov, Lanzhou, Gansu, Peoples R China
来源：
CANCER INVESTIGATION | 2024年 / 42卷 / 10期
关键词：
Endometrial cancer; Circulating tumor cells; Disseminated tumor cells; Prognosis; Management; EARLY-STAGE; MOLECULAR CHARACTERIZATION; BREAST-CANCER; BONE-MARROW; ENRICHMENT; URINE; ENUMERATION; TECHNOLOGY; EXPRESSION; DENSITY;
D O I：
10.1080/07357907.2024.2422607
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Endometrial cancer (EC) is a common gynecological malignancy and its mortality has been increasing in the last twenty years. A growing body of evidence suggests that circulating tumor cells (CTCs) may provide a more complete tumor profile, facilitate the understanding of the molecular mechanism and individual management of EC patients. In this review, we presented the presence and clinical applications of CTCs and disseminated tumor cells (DTCs) in EC, particularly for EC prognosis and management, also highlighted the diagnostic value of tumor cells in urine of EC patients, aim to help researchers better focus on their study in this field.
引用
收藏
页码：845 / 857
页数：13
相关论文
共 50 条
  • [41] Clinical use of circulating tumor cells in the management of patients with breast cancer
    Fritsche, Herbert
    TUMOR BIOLOGY, 2007, 28 : 59 - 59
  • [42] Role of tumor markers and circulating tumors cells in the management of breast cancer
    Saad, Ayman
    Abraham, Jame
    ONCOLOGY-NEW YORK, 2008, 22 (07): : 726 - 731
  • [43] Utility of circulating tumor cells and DNA in the management of advanced colorectal cancer
    Pan, Xiaohong
    Zhang, Xiaoli
    FUTURE ONCOLOGY, 2020, 16 (18) : 1289 - 1300
  • [44] Advances in circulating tumor cells for early detection, prognosis and metastasis reduction in lung cancer
    Wang, Xiaochen
    Bai, Lu
    Kong, Linghui
    Guo, Zhijuan
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [45] Circulating tumor cells in early lobular versus ductal breast cancer and their associations with prognosis
    Alkhafaji, Silver
    Wolf, Denise M.
    Magbanua, Mark Jesus M.
    van 't Veer, Laura J.
    Park, John W.
    Esserman, Laura
    Mukhtar, Rita A.
    NPJ BREAST CANCER, 2024, 10 (01)
  • [46] Circulating tumor cells (CTCs) in breast cancer: a diagnostic tool for prognosis and molecular analysis
    Dong, Xiaoshen
    Alpaugh, R. Katherine
    Cristofanilli, Massimo
    CHINESE JOURNAL OF CANCER RESEARCH, 2012, 24 (04) : 388 - 398
  • [47] Circulating tumor cells(CTCs)in breast cancer:a diagnostic tool for prognosis and molecular analysis
    Xiaoshen Dong
    R.Katherine Alpaugh
    Massimo Cristofanilli
    ChineseJournalofCancerResearch, 2012, 24 (04) : 388 - 398
  • [48] Modalities to enumerate circulating tumor cells in the bloodstream for cancer prognosis and to monitor the response to the therapy
    Romano, G.
    DRUGS OF TODAY, 2017, 53 (09) : 501 - 513
  • [49] Cytokeratin 19-positive circulating tumor cells in early breast cancer prognosis
    Saloustros, Emmanouil
    Mavroudis, Dimitris
    FUTURE ONCOLOGY, 2010, 6 (02) : 209 - 219
  • [50] Prospective study with circulating tumor cells as potential prognosis biomarker in metastatic colorectal cancer
    Souza E Silva, Virgilio
    Abdallah, Emne Ali
    Lopes de Mello, Celso Abdon
    Tariki, Milena Shizue
    Calsavara, Vinicius Fernando
    Chinen, Ludmilla T. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
12345